![Markus J. Cappel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus J. Cappel
Presidente en
OSE IMMUNOTHERAPEUTICS
.
Perfil
Markus J.
Cappel currently works at OSE Immunotherapeutics SA, as Chairman from 2025.
Dr. Cappel also formerly worked at Millennium Pharmaceuticals, Inc., as Director-Business Development, Alkermes, Inc., as Vice President-Business Development from 1998 to 2001, Cygnus, Inc., as Principal, and ChemoCentryx, Inc., as Treasurer & Chief Business Officer from 2007 to 2022.
Dr. Cappel received his undergraduate degree and doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and Masters Business Admin degree from Harvard Business School.
Cargos activos de Markus J. Cappel
| Empresas | Cargo | Inicio |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Presidente | 30/09/2025 |
Antiguos cargos conocidos de Markus J. Cappel.
| Empresas | Cargo | Fin |
|---|---|---|
| CHEMOCENTRYX, INC. | Corporate Officer/Principal | 18/10/2011 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Corporate Officer/Principal | 01/01/2001 |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Formación de Markus J. Cappel.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
40
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
- Bolsa de valores
- Insiders
- Markus J. Cappel
